Diabetic hepatosclerosis: Diabetic microangiopathy of the liver

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 1, 2006, Pages 27-32

  Harrison, Stephen A ^a,b   Brunt, Elizabeth M ^a,b   Goodman, Zachary D ^c   Di Bisceglie, Adrian M ^a,b  

^a Saint Louis University   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AUTONOMIC NEUROPATHY; BASEMENT MEMBRANE; BODY MASS; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC HEPATOSCLEROSIS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FATTY LIVER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; LIVER SINUSOID; MALE; MICROSCOPY; NONALCOHOLIC FATTY LIVER; PERIPHERAL NEUROPATHY; REVIEW;

ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER DISEASES; MALE; MICROCIRCULATION; MIDDLE AGED; SCLEROSIS;

EID: 30444454827     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Shami SK, Chittenden SJ. Microangiopathy in diabetes mellitus, II: features, complications and investigation. Diabetes Res. 1991;17:157-168.
2. Dahl-Jorgensen K. Diabetic microangiopathy. Acta Paediatr Suppl. 1998;425:31-34.
3. Falchuk KR, Fiske SC, Haggitt RC, Federman M, Trey C. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology. 1980;78:535-541.
4. Schaffner F, Popper H. Capillarization of hepatic sinusoids in man. Gastroenterology. 1963;44:239-242.
5. Friedman SL. Cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N Engl J Med. 1993;328:1828-1835.
6. Tsilibary EC. Microvascular basement membranes in diabetes mellitus. J Pathol. 2003;200:537-546.
7. Davi G, Chiarelli F, Santilli F, et al. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation. 2003;107:3199-3203.
8. Bernuau D, Guillot R, Durand AM, et al. Ultrastructural aspects of the liver perisinusoidal space in diabetic patients with and without microangiopathy. Diabetes. 1982;31:1061-1067.
9. Latry P, Bioulac-Sage P, Echinard E, et al. Perisinusoidal fibrosis and basement membrane-like material in the livers of diabetic patients. Hum Pathol. 1987;18:775-780.
10. McGrath NM, Yeong ML. Letter to the editor. Diabet Med. 2000;17:18.
11. Youssef W, McCullough AJ. Diabetes mellitus, obesity, and hepatic steatosis. Semin Gastrointest Dis. 2002;13:17-30.
12. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917-923.
13. Lagiou P, Kuper H, Stuver SO, Tzonou A, Trichopoulos D, Adami HO. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst. 2000;92:1096-1099.
14. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:375-378.
15. Thung SN, Gerber MA, Bodenheimer HC. Nodular regenerative hyperplasia of the liver in a patient with diabetes mellitus. Cancer. 1982;49:543-546.
16. Bernuau D, Guillot R, Durand-Schneider AM, Poussier P, Moreau A, Feldmann G. Liver perisinusoidal fibrosis in BB rats with or without overt diabetes. Am J Pathol. 1985;120:38-45.
17. Hahn E, Wick G, Pencev D, Timpl R. Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin. Gut. 1980;21:63-71.
18. Tsutsumi M, Urashima S, Matsuda Y, Takase S, Takada A. Changes in type IV collagen content in livers of patients with alcoholic liver disease. Hepatology. 1993;17:820-827.